Atea Pharmaceuticals Inc (AVIR)

Investing Cash Flow

$151.95M

TTM · Period ending: · USD

AVIR logo

AVIR Investing Cash Flow

Latest reported$151.95M
AVIR TTM Cash from Investing (-$2.00K → $151.95M)
High-resolution chart · PNG

AVIR investing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Atea Pharmaceuticals Inc Investing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingInvesting Cash Flow (USD)
151,948,000
132,923,000
188,793,000
138,831,000
-24,485,000
84,911,000
56,105,000
87,246,000
150,746,000
72,625,000
40,303,000
46,020,000
-382,442,000
-430,886,000
-455,410,000
-488,902,000
-1,927,000
-48,000
-4,000
-5,000
-20,000
-26,000
-26,000
-21,000
-8,000
-2,000
-2,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.